ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2024

Abstract Number: 0997

Geographic and Lifestyle Exposures in Systemic Lupus Erythematosus

Zoe Reed1, Janis Campbell2, Xana Howard1, Teresa Aberle1, Bridget Parrish1, Wade DeJager3, Cristina Arriens1, Joan Merrill4 and Judith James1, 1Oklahoma Medical Research Foundation, Oklahoma City, OK, 2University of Oklahoma Health Sciences Center, Oklahoma City, OK, 3Oklahoma Medical Research Foundation, Oklahoma City, 4Oklahoma Medical Research Foundation, Oklahoma City 73104, OK

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2024

Keywords: Disparities, Environmental factors, population studies, socioeconomic factors, Systemic lupus erythematosus (SLE)

Session Information

Date: Sunday, November 17, 2024

Title: Epidemiology & Public Health Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic lupus erythematosus (SLE) has a complex etiology with genetic predispositions interacting with environmental factors. Extensive environmental exposure information is now publicly available based on geocode. This study examined the relationship between the residential locations of SLE patients participating in the Oklahoma Cohort of Rheumatic Diseases and geocode-specific information about environmental and lifestyle exposures.

Methods: SLE prevalence rates were calculated for female SLE patients in the Oklahoma Cohort of Rheumatic Disease (OCRD) by county (n=689). Geographic and lifestyle exposure data were sourced from the 2020 County Health Rankings and the 2020 National Environmental Public Health Tracking Network. Explanatory variables explored included the percentage of smokers, percentage of high school graduates, percentage of rural residents, PM2.5 (atmospheric particulate matter < 2.5 um in diameter), primary care physicians per 100,000 population, silica sites, superfund sites, percentage of uninsured adults, and solar irradiance (kJ/m2). Spatial autocorrelation was assessed using a Moran’s I test, which was insignificant (p=0.7205). Therefore, a multiple linear regression model was used to analyze the explanatory variables with SLE rates, and the model with the lowest AIC was chosen. Log transformations were applied to variables exhibiting a right skewness.

Results: The OCRD includes between 1 and 161 per 100,000 individuals from each of 44 counties in Oklahoma (Figure 1). No associations between county-specific environmental exposures and numbers of female SLE patients in the cohort were observed. However, percentages of high school graduates and the percentage of rural residents were negatively associated and solar irradiance was positively associated with numbers of SLE patients in the cohort (Table 1).

Conclusion: Environmental and lifestyle exposures do not seem to affect membership of female SLE patients in the Oklahoma Cohort of Rheumatic Diseases. The cohort is drawing greater numbers of SLE patients from counties with fewer high school graduates, less rural population and a higher UV index. The study is limited in that it is not an incidence or prevalence calculation for SLE, although factors affecting cohort membership, other than distance, may be similar throughout Oklahoma. Further direct comparison of individuals identified from relevant counties may help to determine whether exposure variables are associated with disease severity or cumulative disease activity.

Supporting image 1

Figure 1: Systemic Lupus Erythematosus (SLE) Rates of Females from the Oklahoma Cohort of Rheumatic Disease (OCRD) Cohort by County 2004_2023

Supporting image 2

Table 1: Multiple Linear Regression Model for Explanatory Variables of SLE Rates


Disclosures: Z. Reed: None; J. Campbell: None; X. Howard: None; T. Aberle: None; B. Parrish: None; W. DeJager: None; C. Arriens: AstraZeneca, 1, 5, 6, Aurinia, 1, 6, Bristol-Myers Squibb(BMS), 1, 5, Cabaletta, 1, GlaxoSmithKlein(GSK), 1, Kezar, 1, Synthekine, 1, UCB, 1; J. Merrill: AbbVie, 1, 2, Alexion, 1, 2, Alumis, 1, 2, Amgen, 1, 2, AstraZeneca, 1, 2, 5, Aurinia, 1, 2, Bristol Myers Squibb, 1, 2, 5, EMD Serono, 1, 2, Genentech, 1, 2, Gilead, 1, 2, GlaxoSmithKline, 1, 2, 5, Kezar, 1, 2, Lilly, 1, 2, Merck, 1, 2, Pfizer, 1, 2, Provention, 1, 2, Remegen, 1, 2, Sanofi, 1, 2, Takeda, 1, 2, UCB, 1, 2, Zenas, 1, 2; J. James: GlaxoSmithKlein(GSK), 1, Progentec Diagnostics, Inc., 5, 10.

To cite this abstract in AMA style:

Reed Z, Campbell J, Howard X, Aberle T, Parrish B, DeJager W, Arriens C, Merrill J, James J. Geographic and Lifestyle Exposures in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/geographic-and-lifestyle-exposures-in-systemic-lupus-erythematosus/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/geographic-and-lifestyle-exposures-in-systemic-lupus-erythematosus/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology